&Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
39,665
-13,339
-25% -$149K ﹤0.01% 1950
2026
Q1
$631K Buy
53,004
+8,462
+19% +$86.6K ﹤0.01% 1565
2025
Q4
$444K Buy
44,542
+568
+1% +$5.42K ﹤0.01% 1687
2025
Q3
$394K Buy
43,974
+107
+0.2% +$991 ﹤0.01% 1598
2025
Q2
$414K Buy
+43,867
New +$387K ﹤0.01% 1445

Other funds holding AHCO

&Partners's AHCO Position: Q2 2026 in Review

&Partners reduced its AdaptHealth (AHCO) stake by 25% in Q2 2026, selling an estimated $149K and leaving 39,665 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

&Partners first reported a position in AHCO in Q2 2025 and has held it in 5 quarters since. The position peaked at $631K in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • &Partners held 39,665 shares of AdaptHealth worth $413K as of Q2 2026.
  • &Partners sold 13,339 AdaptHealth shares in Q2 2026, an estimated $149K.
  • AdaptHealth made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1950 holding.
  • &Partners first reported a position in AdaptHealth in Q2 2025 and has held it in 5 quarters since.
  • &Partners's AdaptHealth position peaked at $631K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.